Clinical Trial Update: Study of Adherence Effects and Clinical Outcomes of Kaletra Based HIV Antiviral Therapy [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating adherence effects and clinical outcomes of Kaletra-based HIV therapy has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Kaletra (lopinavir)

Snippet

Sponsor: Abbott | Conditions: HIV Infection | Phase 4 | Status: TERMINATED